Effect of lentinan on lymphocyte subsets of peripheral blood, lymph nodes, and tumor tissues in patients with gastric cancer. 1993

K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
First Department of Surgery, Tokyo Medical and Dental University, School of Medicine, Japan.

The effect of lentinan on lymphocyte subsets of peripheral blood, lymph nodes, and tumor tissues in gastric cancer patients was investigated. A 2-mg dose of lentinan was administered to 12 patients intravenously twice, the first at 3-9 days before and the second the day before surgery. The results were then compared with a control group without lentinan administration comprising 12 patients. Regarding peripheral blood and lymph nodes without metastasis, lymphocyte subsets defined with anti-CD3, anti-CD4, anti-CD8, anti-Leu7, and anti-Leu11 were analyzed by flow-cytometry. As for tumor tissues, lymphocyte subsets defined with anti-CD3, anti-CD4, anti-CD8, anti-Leu11, and anti-M3 were analyzed after immunohistochemical staining. There were no significant changes in the lymphocyte subsets of peripheral blood between the two groups. In the lymph nodes, the CD4 cell ratios increased; otherwise in regard to tumor-infiltrating lymphocytes (TILs), the number of CD4, Leu11 and LeuM3 cells showed a prominent increase. Therefore, lentinan was observed to produce different effects in accordance with the subjective organs.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007912 Lentinan Polysaccharide isolated from the edible mushroom LENTINULA EDODES. The exact composition is unknown.
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
January 1989, Cancer detection and prevention,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
June 1995, Journal of Korean medical science,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
April 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology],
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
May 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
January 2014, Immunology letters,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
December 2016, Iranian journal of immunology : IJI,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
September 1988, Nihon geka hokan. Archiv fur japanische Chirurgie,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
August 1989, Nihon Gan Chiryo Gakkai shi,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
March 2020, BMC cancer,
K Takeshita, and S Watanuki, and M Iida, and N Saito, and M Maruyama, and M Sunagawa, and H Habu, and M Endo
January 1984, Nihon Rai Gakkai zasshi,
Copied contents to your clipboard!